000 | 02140cam a2200397 i 4500 | ||
---|---|---|---|
001 | 19784884 | ||
003 | OSt | ||
005 | 20190531170401.0 | ||
008 | 170713s2018 pau b 001 0 eng | ||
010 | _a2017033412 | ||
020 | _a9781496347282 (paperback) | ||
020 | _a9781496347282 | ||
035 | _a(DNLM)101709391 | ||
040 |
_aDNLM/DLC _cDLC _erda _dDLC |
||
042 | _apcc | ||
050 | 0 | 0 | _b.A57 2018 |
060 | 1 | 0 | _aQV 786 |
072 | 7 |
_aMQP _2thema |
|
082 | 0 | 0 |
_a615.1 _223 |
100 | 1 |
_aAllen, Loyd V., _cJr., |
|
245 | 1 | 0 |
_aAnsel's pharmaceutical dosage forms and drug delivery systems / _cLoyd V. Allen, Jr, PhD, Professor Emeritus, Department of Medicinal Chemistry and Pharmaceutics, College of Pharmacy, University of Oklahoma, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. |
246 | 1 | _aPharmaceutical dosage forms and drug delivery systems | |
250 | _aEleventh edition. | ||
264 | 1 |
_aPhiladelphia : _bWolters Kluwer, _c[2018] |
|
300 |
_ax, 630 pages ; _c28 cm |
||
500 | _aCW108 CW116 | ||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aIntroduction to drugs and pharmacy -- New drug development and approval process -- Current good manufacturing practices and current good compounding practices -- Dosage form design: pharmaceutical and formulation considerations -- Dosage form design: biopharmaceutical and pharmacokinetic considerations -- Powders and granules -- Capsules -- Tablets -- Solid oral modified-release dosage forms and drug delivery systems -- Ointments, creams, and gels -- Transdermals and transdermal drug delivery systems -- Suppositories, inserts, and sticks -- Solutions -- Disperse systems -- Parenterals -- Biologics -- Special solutions and suspensions -- Radiopharmaceuticals -- Products of biotechnology -- Novel dosage forms and drug delivery technologies -- Clinical pharmaceutics. | |
650 | 7 |
_aPharmacy / dispensing _2thema |
|
650 | 1 | 2 | _aDosage Forms |
650 | 2 | 2 | _aDrug Delivery Systems |
942 |
_2ddc _cCW_GL |
||
999 |
_c48650 _d48650 |